INTRONA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Cyprus, Estonia, Ireland, Lithuania, Netherlands, Poland, Singapore.

Active ingredients

The drug INTRONA contains one active pharmaceutical ingredient (API):

1	Interferon, alfa-2b UNII 43K1W2T1M6 - INTERFERON ALFA-2B
	Recombinant interferon alfa-2b is a sterile, stable, formulation of highly purified interferon alfa-2b produced by recombinant DNA techniques. Interferons exert their cellular activities by binding to specific membrane receptors on the cell surface. Recombinant interferon alfa-2b has exhibited antiproliferative effects in studies employing both animal and human cell culture systems as well as human tumour xenografts in animals. It has demonstrated significant immunomodulatory activity in vitro.
	Read more about Interferon, alfa-2b

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INTRONA Solution for injection or infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L03AB05	Interferon alfa-2b	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02223406, 02238674, 02238675
EE	Ravimiamet	1040050, 1040061, 1040072, 1216358, 1216369, 1216370, 1216381, 1216392, 1216404, 1216415, 1216426, 1216437, 1216448, 1216459, 1216460, 1216516, 1216527, 1216538, 1216549, 1216550, 1216561, 1216572, 1216987, 1216998, 1834624, 1834635, 1834646, 1834657, 1834668, 1834679, 1834680, 1834691, 1834703, 1834714, 1834725, 1834736, 1834747, 1834758, 1834769, 1834770, 1834781, 1834792, 1834804
LT	Valstybinė vaistų kontrolės tarnyba	1013461, 1013466, 1013468, 1028545, 1028546, 1028547, 1028548, 1028549, 1028551, 1028552, 1028553, 1028554, 1028555, 1028556, 1028557, 1028558, 1028559, 1028560, 1028561, 1028563, 1028564, 1028565, 1028566, 1028568, 1028569, 1028570, 1028571, 1028572, 1028573, 1028574, 1028575, 1028576, 1079239, 1079240, 1079241, 1079242, 1079243, 1079244, 1079245, 1079246, 1079247, 1085253
NL	Z-Index G-Standaard	14613905
NL	Z-Index G-Standaard, PRK	136255, 64742
PL	Rejestru Produktów Leczniczych	100126264, 100126270, 100126287, 100126293, 100126301, 100126318, 100126324, 100337771
SG	Health Sciences Authority	11010P, 11011P
US	FDA, National Drug Code	0085-1133, 0085-1168